Serum NSE is Early Marker of Transformed Neuroendocrine Tumor After EGFR-TKI Treatment of Lung Adenocarcinoma
Xiaowei Mao,1,2,* Jiabing Liu,3,* Fang Hu,1,* Yanjie Niu,1 Feng Pan,1 Xiaolong Fu,3 Liyan Jiang1 1Pulmonary and Critical Care Medicine, Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai, People’s Republic of China; 2Department of Pulmonary and Critical Care Med...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-03-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/serum-nse-is-early-marker-of-transformed-neuroendocrine-tumor-after-eg-peer-reviewed-fulltext-article-CMAR |